CAS 865479-71-6
:Formule :C19H18ClN3O5S
InChI :InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m1/s1
Code InChI :KGFYHTZWPPHNLQ-CQSZACIVSA-N
SMILES :C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
14 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
Rivaroxaban R-enantiomer
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H18ClN3O5SCouleur et forme :Yellow White SolidMasse moléculaire :435.065575-R-Rivaroxaban
CAS :5-R-Rivaroxaban is the (R)-enantiomer of Rivaroxaban, a potent FXa inhibitor with IC50 0.7 nM and Ki 0.4 nM.Formule :C19H18ClN3O5SDegré de pureté :99.75%Couleur et forme :White SolidMasse moléculaire :435.8815-R-Rivaroxaban
CAS :5-R-RivaroxabanFormule :C19H18ClN3O5SDegré de pureté :99.5%Masse moléculaire :435.88Rivaroxaban EP Impurity A
CAS :Formule :C19H18ClN3O5SCouleur et forme :White To Off-White SolidMasse moléculaire :435.88(R)-Rivaroxaban (5-Chloro-N-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide)
CAS :Produit contrôléFormule :C19H18ClN3O5SCouleur et forme :NeatMasse moléculaire :435.885-Chloro-N-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide
CAS :Formule :C19H18ClN3O5SDegré de pureté :99%Couleur et forme :SolidMasse moléculaire :435.8813ent-Rivaroxaban
CAS :Applications ent-Rivaroxaban is the R-isomer of Rivaroxaban (R538000), which is a novel antithrombotic agent. A highly potent and selective, direct FXa inhibitor.
References Ansell, J., et al.: Drugs, 64, 1 (2004), Eriksson, B., et al.: J. Thromb. Haemost., 3, 103 (2005), Kubitza, D., et al.: Clin. Pharmacol. Ther., 78, 412 (2005),Formule :C19H18ClN3O5SCouleur et forme :NeatMasse moléculaire :435.885-R-Rivaroxaban
CAS :(R)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamideFormule :C19H18ClN3O5SDegré de pureté :99%Masse moléculaire :435.885-Chloro-N-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide
CAS :5-chloro-N-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide (CTP) is a potent inhibitor of the cytochrome P450 enzyme CYP3A4. CTP has been shown to inhibit the metabolism of midazolam, an important drug for general anesthesia and sedation, in a study investigating the interaction between CYP3A4 inhibitors and midazolam. Ketoconazole, another inhibitor of CYP3A4, inhibited the metabolism of midazolam in vitro as well. In addition, CTP was shown to be a substrate for CYP2D6 and CYP1A2 in vitro.Formule :C19H18ClN3O5SDegré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :435.88 g/molent-Rivaroxaban-d4
CAS :Produit contrôléFormule :C19D4H14ClN3O5SCouleur et forme :NeatMasse moléculaire :439.906
![(R)-Rivaroxaban (5-Chloro-N-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-…](https://static.cymitquimica.com/products/86/thumb/MM3629.01.jpg)
![5-Chloro-N-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarbox…](https://static.cymitquimica.com/products/IN/thumb/DA00GU05.jpg)
![5-Chloro-N-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarbox…](https://static.cymitquimica.com/products/3D/thumb/IC71688.jpg)
